Skip to Main Content

Editas Medicine announced the hiring of a new CEO on Thursday — the fourth top executive to lead the troubled maker of gene-editing treatments since 2014.

Gilmore O’Neill takes over as Editas’ CEO on June 1, the company said. He joins from Sarepta Therapeutics, where he served as chief medical officer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment